| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | Canada | 3 | |
| #3 | Israel | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | China | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | South Africa | 2 | |
| #8 | Japan | 1 | |
| #9 | New Zealand | 1 | |
| #10 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Environmental technology | |
| #4 | Machines | |
| #5 | Measurement | |
| #6 | Micro-structure and nano-technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Microorganisms | |
| #4 | Therapeutic chemical compounds | |
| #5 | Ammunition fuzes | |
| #6 | Climate change adaptation technologies | |
| #7 | Fermentation | |
| #8 | Analysing materials | |
| #9 | Nanostructure applications |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chain Daniel G | 14 |
| #2 | Cawthorne Mike | 3 |
| #3 | Chain Benjamin | 2 |
| #4 | Fitzer-Attas Cheryl | 1 |
| #5 | Chain B | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2002086847A1 | Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof | |
| AU3604800A | Method for regulating the stability of recombinant proteins, and antibodies and products useful therein | |
| AU2605600A | Methods for regulating the stability of recombinant proteins and products usefultherein | |
| IL143768D0 | Increasing brain glucose utilization | |
| NZ337765A | Recombinant antibodies having specificity for beta-amyloid N-terminus and C-terminus and use in treating Alzheimer's Disease |